Dermatomyositis as a presentation of neuromyelitis optica spectrum disorder

被引：11

作者：

Delman, David ^{[1
]}

Peng, Xianming ^{[1
]}

Zedek, Daniel C. ^{[2
]}

Jewells, Valerie ^{[3
]}

Chahin, Nizar ^{[1
]}

Markovic-Plese, Silva ^{[1
,4
]}

机构：

[1] Dept Neurol, Chapel Hill, NC 27599 USA

[2] Dept Dermatol, Chapel Hill, NC 27599 USA

[3] Dept Radiol, Chapel Hill, NC 27514 USA

[4] Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA

来源：

JOURNAL OF NEUROIMMUNOLOGY | 2015年 / 278卷

关键词：

Neuromyelitis optica; Dermatomyositis; MDA5; antibody; INTERSTITIAL LUNG-DISEASE; MYOSITIS; AUTOANTIBODIES; INSIGHTS; CANCER;

D O I：

10.1016/j.jneuroim.2014.07.016

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Importance: This is the first report of neuromyelitis optica spectrum disorder (NMOSD) associated with dermatomyositis (DM). Report: A 40 year-old Caucasian female presented with 6 months of worsening fatigue, rash, acute weakness worse in her lower extremities, and urinary retention. She was found to have both NMOSD and anti-melanoma differentiation-associated gene (MDA)5 positive DM with interstitial lung disease (ILD). She was treated aggressively and she regained her ability to ambulate. Conclusion: We recommend considering NMOSD in the differential diagnosis of patients with DM and other autoimmune disorders that also present with clinical signs of myelopathy. (C) 2014 Elsevier B.V. All rights reserved.

引用

页码：108 / 111

页数：4

共 20 条

[1] Anti-MDA5 antibody is associated with A/SIP and decreased T cells in peripheral blood and predicts poor prognosis of ILD in Chinese patients with dermatomyositis [J].

Chen, Fang ;

Wang, Dongxue ;

Shu, Xiaoming ;

Nakashima, Ran ;

Wang, Guochun .

RHEUMATOLOGY INTERNATIONAL, 2012, 32 (12) :3909-3915

[2] Ifih1 Gene Dose Effect Reveals MDA5-Mediated Chronic Type I IFN Gene Signature, Viral Resistance, and Accelerated Autoimmunity [J].

Crampton, Steve P. ;

Deane, Jonathan A. ;

Feigenbaum, Lionel ;

Bolland, Silvia .

JOURNAL OF IMMUNOLOGY, 2012, 188 (03) :1451-1459

[3] An open label study of the effects of rituximab in neuromyelitis optica [J].

Cree, BAC ;

Lamb, S ;

Morgan, K ;

Chen, A ;

Waubant, E ;

Genain, C .

NEUROLOGY, 2005, 64 (07) :1270-1272

[4] Most Patients With Cancer-Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP-2 or Transcription Intermediary Factor 1γ [J].

Fiorentino, David F. ;

Chung, Lorinda S. ;

Christopher-Stine, Lisa ;

Zaba, Lisa ;

Li, Shufeng ;

Mammen, Andrew L. ;

Rosen, Antony ;

Casciola-Rosen, Livia .

ARTHRITIS AND RHEUMATISM, 2013, 65 (11) :2954-2962

[5] Clinical and serological characteristics of 125 Dutch myositis patients - Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies [J].

Hengstman, GJD ;

Brouwer, R ;

Egberts, WTMV ;

Seelig, HP ;

Jongen, PJH ;

van Venrooij, WJ ;

van Engelen, BGM .

JOURNAL OF NEUROLOGY, 2002, 249 (01) :69-75

[6] Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients [J].

Jarius, Sven ;

Ruprecht, Klemens ;

Wildemann, Brigitte ;

Kuempfel, Tania ;

Ringelstein, Marius ;

Geis, Christian ;

Kleiter, Ingo ;

Kleinschnitz, Christoph ;

Berthele, Achim ;

Brettschneider, Johannes ;

Hellwig, Kerstin ;

Hemmer, Bernhard ;

Linker, Ralf A. ;

Lauda, Florian ;

Mayer, Christoph A. ;

Tumani, Hayrettin ;

Melms, Arthur ;

Trebst, Corinna ;

Stangel, Martin ;

Marziniak, Martin ;

Hoffmann, Frank ;

Schippling, Sven ;

Faiss, Juergen H. ;

Neuhaus, Oliver ;

Ettrich, Barbara ;

Zentner, Christian ;

Guthke, Kersten ;

Hofstadt-van Oy, Ulrich ;

Reuss, Reinhard ;

Pellkofer, Hannah ;

Ziemann, Ulf ;

Kern, Peter ;

Wandinger, Klaus P. ;

Bergh, Florian Then ;

Boettcher, Tobias ;

Langel, Stefan ;

Liebetrau, Martin ;

Rommer, Paulus S. ;

Niehaus, Sabine ;

Muench, Christoph ;

Winkelmann, Alexander ;

Zettl U, Uwe K. ;

Metz, Imke ;

Veauthier, Christian ;

Sieb, Joern P. ;

Wilke, Christian ;

Hartung, Hans P. ;

Aktas, Orhan ;

Paul, Friedemann .

JOURNAL OF NEUROINFLAMMATION, 2012, 9

[7] Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica [J].

Jiao, Yujuan ;

Fryer, James P. ;

Lennon, Vanda A. ;

Jenkins, Sarah M. ;

Quek, Amy M. L. ;

Smith, Carin Y. ;

McKeon, Andrew ;

Costanzi, Chiara ;

Iorio, Raffaele ;

Weinshenker, Brian G. ;

Wingerchuk, Dean M. ;

Shuster, Elizabeth A. ;

Lucchinetti, Claudia F. ;

Pittock, Sean J. .

NEUROLOGY, 2013, 81 (14) :1197-1204

[8] Myositis autoantibodies in Korean patients with inflammatory myositis: Anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis [J].

Kang, Eun Ha ;

Nakashima, Ran ;

Mimori, Tsuneyo ;

Kim, Jinhyun ;

Lee, Yun Jong ;

Lee, Eun Bong ;

Song, Yeong Wook .

BMC MUSCULOSKELETAL DISORDERS, 2010, 11

[9] A 5-Year Follow-up of Rituximab Treatment in Patients With Neuromyelitis Optica Spectrum Disorder [J].

Kim, Su-Hyun ;

Huh, So-Young ;

Lee, Sun Ju ;

Joung, Aeran ;

Kim, Ho Jin .

JAMA NEUROLOGY, 2013, 70 (09) :1110-1117

[10] A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis [J].

Lennon, VA ;

Wingerchuk, DM ;

Kryzer, TJ ;

Pittock, SJ ;

Lucchinetti, CF ;

Fujihara, K ;

Nakashima, I ;

Weinshenker, BG .

LANCET, 2004, 364 (9451) :2106-2112

← 1 2 →